Deborah Evrard

Deborah Evrard has a diverse work experience. Deborah started their career at Eli Lilly in 1994 as a Senior Organic Chemist, where they contributed to the discovery of novel therapeutic agents for diabetes and obesity. Deborah then joined Pfizer in 1998 as a Principal Research Scientist, where they led structure-activity relationship studies and advanced drug candidates for the treatment of depression and chronic pain. In 2012, Deborah founded and managed their own company, D & B Assets, LLC, which involved researching distressed real estate properties and overseeing investments. Since 2015, they have been working as a Principal Scientist at Abzena.

Deborah Evrard holds a Ph.D. in Synthetic Organic Chemistry from Harvard University (1988-1994) and a B.S. in Chemistry from the University of Louisville (1981-1985).